Metabolomics approach by 1H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Metabolomics approach by 1H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout ; volume:20 ; number:1 ; day:5 ; month:6 ; year:2018 ; pages:1-11 ; date:12.2018
Arthritis Research & Therapy ; 20, Heft 1 (5.6.2018), 1-11, 12.2018
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Zhang, Yannan
- Beteiligte Personen und Organisationen
-
Zhang, Huanzhen
Chang, Dong
Guo, Fuchuan
Pan, Hongzhi
Yang, Yuexin
SpringerLink (Online service)
- DOI
-
10.1186/s13075-018-1600-5
- URN
-
urn:nbn:de:101:1-2018081122310566285510
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, Yannan
- Zhang, Huanzhen
- Chang, Dong
- Guo, Fuchuan
- Pan, Hongzhi
- Yang, Yuexin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Susceptibility genes of hyperuricemia and gout
Circulating microRNA alternations in primary hyperuricemia and gout
The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: a cross-sectional study
Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
Metabolomic analysis for asymptomatic hyperuricemia and gout based on a combination of dried blood spot sampling and mass spectrometry technology
NUMB dysfunction defines a novel mechanism underlying hyperuricemia and gout
Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome
Ultrasonographic findings in patients with chronic kidney disease with asymptomatic hyperuricemia
Investigation of pathogenesis of hyperuricemia based on untargeted and targeted metabolomics
Hidden gout- Ultrasound findings in patients with musculo-skeletal problems and hyperuricemia
Asymptomatic hyperuricemia associated with increased risk of nephrolithiasis: a cross-sectional study
Susceptibility genes of hyperuricemia and gout
Circulating microRNA alternations in primary hyperuricemia and gout
The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: a cross-sectional study
Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
Metabolomic analysis for asymptomatic hyperuricemia and gout based on a combination of dried blood spot sampling and mass spectrometry technology
NUMB dysfunction defines a novel mechanism underlying hyperuricemia and gout
Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome
Ultrasonographic findings in patients with chronic kidney disease with asymptomatic hyperuricemia
Investigation of pathogenesis of hyperuricemia based on untargeted and targeted metabolomics
Hidden gout- Ultrasound findings in patients with musculo-skeletal problems and hyperuricemia
Asymptomatic hyperuricemia associated with increased risk of nephrolithiasis: a cross-sectional study
Susceptibility genes of hyperuricemia and gout
Circulating microRNA alternations in primary hyperuricemia and gout
The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: a cross-sectional study
Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
Metabolomic analysis for asymptomatic hyperuricemia and gout based on a combination of dried blood spot sampling and mass spectrometry technology
NUMB dysfunction defines a novel mechanism underlying hyperuricemia and gout
Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome
Ultrasonographic findings in patients with chronic kidney disease with asymptomatic hyperuricemia
Investigation of pathogenesis of hyperuricemia based on untargeted and targeted metabolomics
Hidden gout- Ultrasound findings in patients with musculo-skeletal problems and hyperuricemia